Anti-coagulant Treatment of Cancer-Associated Thrombosis in Frail Patients: Impact of Frailties on the Management of Drug–Drug Interactions Claire GrangeCatherine RioufolSouad Assaad Review Article Open access 12 October 2023 Pages: 1523 - 1531
Clinical Pharmacokinetics of Ponesimod, a Selective S1P1 Receptor Modulator, in the Treatment of Multiple Sclerosis Terra M. KrugerBelén ValenzuelaJuan Jose Perez Ruixo Review Article 30 September 2023 Pages: 1533 - 1550
Bridging the Worlds of Pharmacometrics and Machine Learning Kamilė StankevičiūtėJean-Baptiste WoillardMihaela van der Schaar Review Article 06 October 2023 Pages: 1551 - 1565
Pharmacokinetics of Oral Vitamin D in Children with Obesity and Asthma Jason E. LangRodrigo Gonzalez RamirezLaura James Original Research Article Open access 30 August 2023 Pages: 1567 - 1579
Pharmacokinetics of Henagliflozin in Dialysis Patients with Diabetes Li DingShang LiuLeyi Gu Original Research Article 15 September 2023 Pages: 1581 - 1587
Irinotecan-Induced Toxicity: A Pharmacogenetic Study Beyond UGT1A1 Mirjam de WithLeni van DoornSander Bins Original Research Article Open access 16 September 2023 Pages: 1589 - 1597
Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation Sarah BakloutiEmmanuelle CometsDidier Concordet Original Research Article Open access 17 September 2023 Pages: 1599 - 1609
Cannabidiol Exposure Through Maternal Marijuana Use: Predictions in Breastfed Infants Cindy H. T. YeungKerri A. BertrandAndrea N. Edginton Original Research Article 21 September 2023 Pages: 1611 - 1619
Escitalopram and Sertraline Population Pharmacokinetic Analysis in Pediatric Patients Ethan A. PoweleitZachary L. TaylorLaura B. Ramsey Original Research Article 27 September 2023 Pages: 1621 - 1637
Assessing QTc Effects of Vericiguat Using Two Different Concentration-QTc Modeling Approaches Hauke RuehsAlexander SolmsMichaela Meyer Original Research Article Open access 06 September 2023 Pages: 1639 - 1648
Comment on: Evaluation of the Influence of Sildenafil on the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults Mustafa GanijeeGaayen Ravii SahgalMalik Takreem Ahmad Letter to the Editor 26 September 2023 Pages: 1649 - 1650
Authors’ Reply to Ganijee et al.: “Comment on: Evaluation of the Influence of Sildenafil on Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Vericiguat in Healthy Adults” Michael BoettcherCorina Becker Letter to the Editor Open access 26 September 2023 Pages: 1651 - 1653